Navigation Links
Quark Pharmaceuticals Appoints New Chief Medical Officer
Date:9/4/2007

FREMONT, Calif., Sept. 4 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel RNA interference-based therapeutics, announced today that J. Joseph Marr, M.D. has been appointed as the Company's new Chief Medical Officer.

In this capacity, Dr. Marr will play a key role in supporting Quark's current clinical programs and in outlining the goals and plans of the Company's pipeline.

Prior to joining Quark, Dr. Marr served as President of BioMed, LLC, a medical and biotechnology consulting company, since 1999. He simultaneously served as General Partner of Pacific Rim Ventures, a venture capital firm, since 2000. Previously, Dr. Marr held positions at Immulogic Pharmaceutical Corporation from 1996 to 1999, serving most recently as President, CEO, and member of the Board of Directors. Dr. Marr previously served as Vice President, Research and Development of Ribozyme Pharmaceuticals, Inc. and as Senior Vice President, Discovery Research at Monsanto Searle Research and Development. Dr. Marr received a Doctorate of Medicine from The Johns Hopkins University School of Medicine and has held professorial positions at University of Colorado Health Sciences Center, St. Louis University School of Medicine, and Washington University School of Medicine.

Daniel Zurr, CEO of Quark Pharmaceuticals, commented, "Dr. Marr brings to Quark nearly 20 years experience in clinical research positions at note worthy pharmaceutical companies, including Immulogic and Ribozyme. His extensive experience as a consultant to global pharmaceutical companies, combined with his past work as a practicing physician, adds to the depth of our team as we aggressively expand our clinical trials program. With his addition, we are well prepared to meet the increasing workload of our extensive clinical pipeline."

Currently Quark is conducting a Phase I/IIa clinical trial for its lead product candidate, RTP80
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCall/ -... results for its first quarter ended September 30,...diluted share, on revenues of $3,263,000. This co...iluted share, on revenues of $3,168,000 for the fi...first quarter results, Biotel President and CEO St...
(Date:11/20/2009)..., MEMPHIS, Tenn., Nov. 20 /PRNewswire-FirstCa...dics Division is pleased to announce the signing o...d States Department of Defense that may lead to th...to revolutionize the treatment of the limbs of sol... year, the Defense Advanced Research Projects Agen...
(Date:11/19/2009)... , LYON, France, Nov. 19 In res...plying dangerous and illegal medicines, Operation ... by INTERPOL and the World Health Organization,s I...Taskforce (IMPACT) to highlight the dangers of buy...nitiative resulted in a series of arrests and the ...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Illinois Awards Program Integrity Contract to HMS 59626 1Frost 26amp 3B Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low Dose Contraceptive Patch 14508 1Frost 26amp 3B Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low Dose Contraceptive Patch 14508 2Frost 26amp 3B Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low Dose Contraceptive Patch 14508 3Frost 26amp 3B Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low Dose Contraceptive Patch 14508 4Frost 26amp 3B Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low Dose Contraceptive Patch 14508 5Oxygen Biotherapeutics Inc to Webcast Shareholder Meeting 5524 1
(Date:11/21/2009)...whether there is a secret to ,alcohol rehab succes... London, UK (PRWEB) November 21, 2009 -- Linwoo... adult UK population drinking enough alcohol to cr...sease*, it is hardly a surprise that many are incr...residential centres for help. However, for someone...
(Date:11/20/2009)...e/ -- Following a recall by Unilever The Stop &...,s Country Crock ® Side Dishes DELUXE Cheddar...de Dishes DELUXE Four Cheese Pasta due to an undec...dates and UPCs are affected: ,, Shedd,s Countr... Rice 21 oz, UPC 027400218316, Best By NOV 29 09 t...
(Date:11/20/2009)... Cardio Vascular,Medical...OM , a leading,developer of advanced cardiovascula...pany,s Board of Directors has decided to initiate ...East for its proprietary next-generation,"steerabl... procedures. , Cardio Vascular Medical De...
(Date:11/20/2009)... used for embalming in the funeral industry were a...loid leukemia, according to a new study published ... Cancer Institute . , Previous studies have show...ancies and brain cancer in anatomists, pathologist...ave worked with formaldehyde. , For this study...
(Date:11/20/2009)... supply, study finds , , FRIDAY, Nov. 20...f prescription drugs is up to one-third cheaper th...tudy. , U.S. researchers analyzed 26,852 prescr..., and found that patients who bought a three-month...rage 29 percent in out-of-pocket costs. After the ...
Breaking Medicine News(10 mins):Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Three-Month Supply Lowers Drug Costs 2
...the central nervous system caused by the Taenia so...common type of acquired epilepsy around the world....cts about 400,000 people. New research shows an... albendazole which they thought might help these p...
...ired for success in school are similar to those re... that one’s cognitive abilities predict success in...n controversial. Many people believe what is neede...performance in the academic world overlap with abi...
...elp explain their disease more clearly. A new stud...ildren // have a different disease than those who ...ts suffered different symptoms and disease progres...ivided into two groups including those diagnosed b...
...an adult disease, but now more children are being ...own girls are affected more than boys. Now, a new ...erence between girls and boys being diagnosed with...e study included 307 healthy children 4 or 5 years...
...rs say the risks and benefits of using CT scanning...Researchers from Sweden studied more than 3,000 me...of age. Participants had their intellectual capaci...eived increasing doses of radiation in the front a...
...e of sudden cardiac arrest in North America and Eu...eart rhythm disturbance. When medical personnel...ular fibrillation, in which the heart's main pumpi...atients who have been down longer, have asystole, ...
Other Medicine News:Health News:Onset Linked To Severity of Asthma 2Health News:Vasopressin Found To Boost Survival In Sudden Cardiac arrest 2
...allows the laboratory to verify automatic pipets w...e of the pipet. Each PVS kit contains six vials of...ting Solution. Using the pipet or dilutor to be ve...tions. The kit is then returned to Streck for anal...
...ck Cytometry Concentrate is for use as a sheath fl...ch 70ml bottle of Cytometry Concentrate dilutes to... to Cubitainers, Streck Cytometry Concentrate redu...s money without compromising performance. Streck C...
Cyto-Chex Storage and Transport Solution
Streck-ONYX-Pack Diluent and Lysing Agent
Medicine Products: